Investigating how donor kidney macrophages affect inflammation and immune response after transplantation
Donor Kidney Resident Macrophages in Kidney Allograft Early Inflammation and Alloimmunity
This study is looking at how certain immune cells in donated kidneys affect inflammation right after a transplant, with the goal of finding ways to improve kidney transplant success and help patients need less medication to prevent rejection.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11039941 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of donor kidney resident macrophages in the early inflammation that occurs after kidney transplantation. It aims to identify how these macrophages influence the immune response and the overall success of the transplant. By studying the behavior of these cells and their production of specific signals, the research seeks to develop strategies that could improve kidney transplant outcomes. Patients may benefit from insights that could lead to better management of kidney transplants and potentially reduce the need for long-term immunosuppression.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with end-stage renal disease who are considering or awaiting kidney transplantation.
Not a fit: Patients who have already received a kidney transplant and are not experiencing complications related to inflammation or alloimmunity may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved kidney transplant outcomes and reduced reliance on immunosuppressive medications for patients.
How similar studies have performed: Previous research has shown promising results in understanding the role of macrophages in transplant rejection, suggesting that this approach could lead to significant advancements in transplant medicine.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Luo, Xunrong — Duke University
- Study coordinator: Luo, Xunrong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.